Literature DB >> 12065584

Two parallel pathways mediate cytoplasmic localization of the dioxin (aryl hydrocarbon) receptor.

Petra Berg1, Ingemar Pongratz.   

Abstract

The dioxin receptor is a ligand-dependent transcription factor that mediates the biological effects of dioxin and related environmental pollutants. In the absence of ligand the receptor is present in the cytoplasmic compartment of the cell associated with the hsp90-dependent chaperone complex. This complex regulates several functions of the receptor such as ligand binding and nuclear import. Furthermore, intracellular localization of the receptor is modulated by multiple factors such as the export protein CRM-1 and the hsp90-associated immunophilin XAP-2. We have identified the mechanism of XAP-2-induced cytoplasmic localization of the receptor and studied the potential cross-talk between CRM-1 and XAP-2. We show that XAP-2 anchors the ligand-free receptor to cytoskeletal structures. This effect is blocked upon treatment with the actin inhibitor cytochalasin B, whereas the tubulin inhibitor colchicine had no effect on receptor localization. In addition, we show that the receptor interacts with CRM-1 both in the presence and absence of ligand. CRM-1-mediated nuclear export occurs independently of XAP-2. Our data provide evidence that CRM-1 and XAP-2 act in parallel through different mechanisms and target different interfaces of the receptor. These results suggest that two pathways cooperate to localize the non-activated receptor in the cytoplasmic compartment of the cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065584     DOI: 10.1074/jbc.M203351200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation.

Authors:  Qian Yu; Yann-Yin Lee; Zheng-Yun Xia; Emily C Liong; Jia Xiao; George L Tipoe
Journal:  Eur J Nutr       Date:  2020-06-17       Impact factor: 5.614

2.  Loss of hepatic aryl hydrocarbon receptor protein in adrenalectomized rats does not involve altered levels of the receptor's cytoplasmic chaperones.

Authors:  Chunja Lee; Anne K Mullen Grey; David S Riddick
Journal:  Can J Physiol Pharmacol       Date:  2013-08-16       Impact factor: 2.273

3.  Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK.

Authors:  Un-Ho Jin; Keshav Karki; Sang-Bae Kim; Stephen Safe
Journal:  Biochem Biophys Res Commun       Date:  2018-06-27       Impact factor: 3.575

4.  Actin cytoskeleton is required for nuclear accumulation of Gln3 in response to nitrogen limitation but not rapamycin treatment in Saccharomyces cerevisiae.

Authors:  Kathleen H Cox; Jennifer J Tate; Terrance G Cooper
Journal:  J Biol Chem       Date:  2004-02-16       Impact factor: 5.157

5.  Tryptamine serves as a proligand of the AhR transcriptional pathway whose activation is dependent of monoamine oxidases.

Authors:  Linda Vikström Bergander; Wen Cai; Bernward Klocke; Martin Seifert; Ingemar Pongratz
Journal:  Mol Endocrinol       Date:  2012-08-03

Review 6.  The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity.

Authors:  Maria Florencia Torti; Federico Giovannoni; Francisco Javier Quintana; Cybele Carina García
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

7.  The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α.

Authors:  Wen Cai; Tatiana V Kramarova; Petra Berg; Marta Korbonits; Ingemar Pongratz
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

8.  Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland.

Authors:  Laura C Hernández-Ramírez; Rhodri M L Morgan; Sayka Barry; Fulvio D'Acquisto; Chrisostomos Prodromou; Márta Korbonits
Journal:  Oncotarget       Date:  2018-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.